Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 3 Similar Profiles
Rheumatoid Arthritis
Medicine & Life Sciences
Antirheumatic Agents
Medicine & Life Sciences
Nontuberculous Mycobacteria
Medicine & Life Sciences
Tumor Necrosis Factor-alpha
Medicine & Life Sciences
Infection
Medicine & Life Sciences
Tuberculosis
Medicine & Life Sciences
Biological Therapy
Medicine & Life Sciences
Nontuberculous Mycobacterium Infections
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2020
P2 Study of Clofazimine for Pulmonary M. avium Disease IND 125,266 (1/5/2015)
9/1/16 → 7/31/20
Project: Research project › Research Project
Clofazimine
Mycobacterium avium Complex
Lung
Lung Diseases
Orphan Drug Production
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Winthrop, K. & Curtis, J. R.
9/1/14 → 8/31/19
Project: Research project › Research Project with Complex Structure Cooperative Agreement
Herpes Zoster Vaccine
Chickenpox Vaccine
Herpes Zoster
Safety
Rheumatoid Arthritis
Mycobacterial disease prevention: pharmacovigilance and inflammatory disease
9/30/08 → 9/29/11
Project: Research project › Clinical Investigator Award (CIA)
Pharmacovigilance
Biological Therapy
Tumor Necrosis Factor-alpha
Immunosuppressive Agents
Infection
Research Output 1997 2018
Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration
Jones, M. M., Winthrop, K. L., Nelson, S. D., Duvall, S. L., Patterson, O. V., Nechodom, K. E., Findley, K. E., Radonovich, L. J., Samore, M. H. & Fennelly, K. P., Jun 1 2018, In : PLoS One. 13, 6, 0197976Research output: Contribution to journal › Article
veterans
Veterans Health
mycobacterial diseases
United States Department of Veterans Affairs
epidemiology
4
Citations
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (Soluble immune effector molecules [II]: Agents targeting interleukins, immunoglobulins and complement factors)
Winthrop, K. L., Mariette, X., Silva, J. T., Benamu, E., Calabrese, L. H., Dumusc, A., Smolen, J. S., Aguado, J. M. & Fernández-Ruiz, M., Jan 1 2018, (Accepted/In press) In : Clinical Microbiology and Infection.Research output: Contribution to journal › Article
LY2439821
Interleukin 1 Receptor Antagonist Protein
Biological Therapy
Interleukins
Communicable Diseases
Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: A randomised clinical trial
Park, J. K., Lee, Y. J., Shin, K., Ha, Y. J., Lee, E. Y., Song, Y. W., Choi, Y., Winthrop, K. L. & Lee, E. B., Jun 1 2018, In : Annals of the Rheumatic Diseases. 77, 6, p. 898-904 7 p.Research output: Contribution to journal › Article
Methotrexate
Human Influenza
Rheumatoid Arthritis
Vaccination
Randomized Controlled Trials
Interventions to reduce inappropriate prescribing of antibiotics for acute respiratory tract infections: summary and update of a systematic review
McDonagh, M. S., Peterson, K., Winthrop, K., Cantor, A., Lazur, B. H. & Buckley, D. I., Aug 1 2018, In : Journal of International Medical Research. 46, 8, p. 3337-3357 21 p.Research output: Contribution to journal › Review article
Inappropriate Prescribing
Respiratory Tract Infections
Anti-Bacterial Agents
Calcitonin
Patient Education
2
Citations
Multicenter study of QuantiFERON®-TB Gold Plus in patients with active tuberculosis
Horne, D. J., Jones, B. E., Kamada, A., Fukushima, K., Winthrop, K. L., Siegel, S. A. R., Kovacs, A., Anthony, P., Meekin, K. A., Bhat, S., Kerndt, P., Chang, A., Koelle, D. M. & Narita, M., Jun 1 2018, In : International Journal of Tuberculosis and Lung Disease. 22, 6, p. 617-621 5 p.Research output: Contribution to journal › Article
Gold
Multicenter Studies
Tuberculosis
Antigens
Peptides